European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
Robert Knobler(Medical University of Vienna), Thomas Krieg(University of Cologne), Ivan Foeldvari(Center for Rheumatology), Vanessa Smith(Ghent University Hospital), Jaana Panelius(University of Helsinki), Michael Sticherling(Universitätsklinikum Erlangen), Maurizio Cutolo(Ospedale Policlinico San Martino), C. Françès(Navarre Institute of Health Research), Cord Sunderkötter(MSB Medical School Berlin), G. Bali(Semmelweis University), Veli‐Matti Kähäri(University of Turku), Alain Taı̈eb(Université de Bordeaux), Ahmad Jalili(Medical University of Vienna), L.A. Frasin(Alessandro Manzoni Hospital), Nicolas Hunzelmann(University Hospital Cologne), Margitta Worm(Charité - Universitätsmedizin Berlin), Ulrike Just(University Hospital Heidelberg), Dorota Krasowska(Medical University of Lublin), Lidia Rudnicka(Medical University of Warsaw), Peter Wolf(University Hospital Heidelberg), Pietro Quaglino(Department of Medical Sciences), Anna Skrok(Medical University of Warsaw), M. Bagot(Inserm), Adrian Tanew(Universitätszahnklinik Wien), Pia Moinzadeh(University of Cologne), Klaus F. Kofoed(University of Copenhagen), Annamari Ranki(University of Helsinki), Jean‐David Bouaziz(Université Paris Cité), Małgorzata Olszewska(Medical University of Warsaw), Julien Sénéschal(Hôpital Saint-André), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Franco Rongioletti(Vita-Salute San Raffaele University), Elisabeth Aberer(Medical University of Graz), Aurora Parodi(Ospedale Policlinico San Martino), Anne Braae Olesen(Aarhus University Hospital), Christopher P. Denton(The Royal Free Hospital), A. Petit(Hôpital Saint-Louis), Antonio Cozzio(Ostschweizer Kinderspital), Nora Wutte(Medical University of Graz), J Schmidt(FH Münster), Luc Mouthon(Université Paris Cité), Catherine H. Orteu(The Royal Free Hospital), Sarolta Kárpáti(Semmelweis University)
Cited by 261
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
World Allergy Organization Anaphylaxis Guidance 2020
|World Allergy Organization Journal|2020|1.1k